These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2041145)

  • 61. [Clinical evaluation of latamoxef, an oxacephem antibiotic with special reference to transport of latamoxef into the lung tissues and prevention of postoperative infections after thoracotomy].
    Imaizumi M; Kimura J; Akiyama S; Uchida T; Ichimura I; Hirai K; Kawahara K; Kondo T
    Jpn J Antibiot; 1983 Aug; 36(8):2081-92. PubMed ID: 6655826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pharmacokinetic and clinical studies on flomoxef in the pediatric field].
    Ito M; Ihara T; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1987 Aug; 40(8):1407-17. PubMed ID: 3430716
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam].
    Fujii R; Abe T; Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Kusumoto Y; Iwata S; Satoh Y; Toyonaga Y; Ishihara T; Nakamura H; Iwai N; Nakamura H; Kuno K; Katoh T; Ogawa A; Itomi K; Okumura A; Hayakawa F; Takahashi H; Etoh M
    Jpn J Antibiot; 1997 Jul; 50(7):597-621. PubMed ID: 9743906
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery.
    Burkhardt O; Majcher-Peszynska J; Borner K; Mundkowski R; Drewelow B; Derendorf H; Welte T
    J Clin Pharmacol; 2005 Jun; 45(6):659-65. PubMed ID: 15901747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The penetration of novel intravenous cephalosporins into the lung.
    Baldwin DR
    J Chemother; 1996 Feb; 8 Suppl 2():71-82. PubMed ID: 8738849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Serum and sputum levels of cefotetan used in respiratory tract infections].
    Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
    Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical studies of flomoxef in the field of obstetrics and gynecology].
    Doko F
    Jpn J Antibiot; 1987 Oct; 40(10):1830-4. PubMed ID: 3444024
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Laboratory and clinical studies of flomoxef].
    Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H
    Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Laboratory and clinical studies on cefamandole in pediatric field (author's transl)].
    Hori M; Kohno S; Hashimoto F; Matsunaga T; Kurosu Y; Toyonaga Y; Takahashi T
    Jpn J Antibiot; 1979 Nov; 32(11):1091-100. PubMed ID: 513291
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery].
    Shinagawa N; Mizuno I; Fukui T; Takeyama H; Yasuda A; Matsumoto K; Ueda N; Mouri N; Nagasaki T; Yokoyama T; Shinbara K; Isaka M; Kurisu Y; Akagi S; Tagawa K; Kano M; Niitani N; Watatani Y
    Jpn J Antibiot; 2006 Dec; 59(6):417-27. PubMed ID: 17334060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
    Kaino Y; Kida K; Matsuda H
    Jpn J Antibiot; 1994 Nov; 47(11):1565-75. PubMed ID: 7853687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
    Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
    Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D; Jougon J; Djabarouti S; Gordien JB; Xuereb F; Velly JF; Arvis P; Landreau V; Saux MC
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The penetration of cefpirome into the potential sites of pulmonary infection.
    Baldwin DR; Maxwell SR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1991 Jul; 28(1):79-86. PubMed ID: 1769946
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical evaluation of flomoxef in pediatrics and a study on the penetration into cerebrospinal fluid].
    Okada T; Furukawa S
    Jpn J Antibiot; 1987 Aug; 40(8):1477-85. PubMed ID: 3430723
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Postoperative infections in cardiovascular surgery: what is an appropriate prophylactic administration of antibiotics?].
    Matsumoto H; Yamashita M; Iguro Y; Miyazaki T; Taira A
    Kyobu Geka; 1995 May; 48(5):375-9. PubMed ID: 7745860
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Study on flomoxef in the perinatal period].
    Tamate K; Sengoku K; Ishikawa M; Shimizu T; Haga H; Hasegawa T; Takada H; Mure K; Kawamura M; Torii Y
    Jpn J Antibiot; 1991 Jun; 44(6):643-51. PubMed ID: 1890723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Basic and clinical studies on clarithromycin in pediatrics].
    Iwai N; Taneda Y; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1989 Feb; 42(2):304-22. PubMed ID: 2526244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.